Nuzenio

Chmp

Chmp news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 6 latest news signals 5 publisher sources 100/100 entity strength

Latest news

NewAmsterdam reports $64.1M Q2 net loss, $678.3M cash; CHMP recommends obicetrapib approval - TradingViewTradingView · Wed, 05 Aug 2026 11:13:00 GMTLynavoy recommended for EU approval by the CHMP - PharmaTimesPharmaTimes · Thu, 30 Jul 2026 07:00:00 GMTCHMP backs first CETP inhibitor after two decades of failure - European Biotechnology MagazineEuropean Biotechnology Magazine · Wed, 29 Jul 2026 07:56:48 GMTPOSITIVE CHMP OPINION SUPPORTS BROADER USE OF AMGEN'S REPATHA® BEFORE A FIRST HEART ATTACK OR STROKE - AmgenAmgen · Wed, 29 Jul 2026 07:00:00 GMTCHMP Backs Roche’s Susvimo for Wet AMD, European Commission Decision Pending - Eyewire+Eyewire+ · Tue, 28 Jul 2026 18:13:12 GMTNezglyal receives positive CHMP opinion supporting treatment access for boys with cALD - PharmaTimesPharmaTimes · Tue, 28 Jul 2026 10:03:00 GMT

Timeline

Wed, 05 Aug 2026 11:13:00 GMTNewAmsterdam reports $64.1M Q2 net loss, $678.3M cash; CHMP recommends obicetrapib approval - TradingView
Thu, 30 Jul 2026 07:00:00 GMTLynavoy recommended for EU approval by the CHMP - PharmaTimes
Wed, 29 Jul 2026 07:56:48 GMTCHMP backs first CETP inhibitor after two decades of failure - European Biotechnology Magazine
Wed, 29 Jul 2026 07:00:00 GMTPOSITIVE CHMP OPINION SUPPORTS BROADER USE OF AMGEN'S REPATHA® BEFORE A FIRST HEART ATTACK OR STROKE - Amgen
Tue, 28 Jul 2026 18:13:12 GMTCHMP Backs Roche’s Susvimo for Wet AMD, European Commission Decision Pending - Eyewire+
Tue, 28 Jul 2026 10:03:00 GMTNezglyal receives positive CHMP opinion supporting treatment access for boys with cALD - PharmaTimes

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Chmp.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

5 distinct publisher/source names are currently connected to this entity page.